Results 61 to 70 of about 1,001,986 (296)

To Biopsy a Small Renal Mass, or Not? [PDF]

Nephro-Urology Monthly, 2012
The abundant use of cross-sectional imaging has markedly increased the diagnosis of small renal masses (SRMs) (1). A strict definition of small renal masses is lacking and most authors consider lesions < 4cm as small (2). According to the literature, 20% of SRMs are benign in formal histological results and SRMs represent 48-66% of diagnosed renal cell
Chatzidarellis, E., Skolarikos, A., Papatsoris, A.G.   +2 more
openaire   +3 more sources

Characteristics and Outcomes of Male Participants in a Multicenter Longitudinal Australian Study Cohort

Arthritis Care &Research, EarlyView.
Objective The aim of this study was to determine the differences in demographic, serologic, and clinical characteristics between male and female patients with systemic sclerosis (SSc) in an Australian cohort. Methods This was a retrospective observational study using data from the Australian Scleroderma Cohort Study.
Emily Lin, Dylan Hansen, Laura Ross, Gene‐Siew Ngian, Susanna Proudman, Gabor Major, Maryam Tabesh, Mandana Nikpour, Jennifer Walker, Lauren Host, Nava Ferdowsi, Alannah Quinlivan, Wendy Stevens, Joanne Sahhar, Diane Apostolopoulos   +14 more
wiley   +1 more source

Percutaneous needle biopsy for indeterminate renal masses: a national survey of UK consultant urologists

BMC Urology, 2007
Background The use of percutaneous needle biopsy in the evaluation of indeterminate renal masses is controversial and its role in management remains largely unclear. We set to establish current practice on this issue in UK urology departments. Methods We
Arya Manit, Quereshi Sheila, Shergill Iqbal S, Khan Azhar A, Vandal Mohammed T, Gujral Sandeep S   +5 more
doaj   +1 more source

Real world outcomes of biopsy‐proven oncocytic neoplasm of the kidney managed by surveillance

BJUI Compass, 2022
Objectives To evaluate outcomes of patients diagnosed with oncocytic renal neoplasms on routine renal mass biopsy and to describe the natural history of these tumours when managed with surveillance as opposed to immediate intervention.
Flora E. Rodger, Keiran Brown, Steve Leung, Jack Coode‐Bate, James Armitage, Anne Warren, Jane Hendry, Grant D. Stewart, Alex Laird, Grenville M. Oades   +9 more
doaj   +1 more source

Pathological Interpretation of Renal Mass Biopsies

, 2020
Renal tumors are predominantly of epithelial, mesenchymal, or mixed-cell origin. Each category can be subclassified as benign or malignant. Renal cell carcinomas (RCCs; malignant epithelial tumors) encompass a large heterogeneous group of cancers derived
Fiona Hanly, Andre Pinto, de Lima Guido, Luiz Paulo, Britney Escobedo, Pinto, Andre, Jorda, Merce, Hanly, Fiona, Escobedo, Britney, Luiz Paulo de Lima Guido, Merce Jorda   +9 more
core   +1 more source

Clinical, Histologic, and Serological Predictors of Renal Function Loss in Lupus Nephritis

Arthritis Care &Research, EarlyView.
Objective Kidney survival is the ultimate goal in lupus nephritis (LN) management, but long‐term predictors remain inadequately studied, requiring long‐term follow‐up. This study aimed to identify baseline and early longitudinal predictors of kidney survival in the Accelerating Medicines Partnership LN longitudinal cohort.
Shangzhu Zhang, Laurence Magder, Daniel Goldman, Judith A. James, Joel M. Guthridge, Carla Guthridge, Peter Izmirly, Jill P. Buyon, H. Michael Belmont, Richard A. Furie, Noa Schwartz, Chaim Putterman, Jennifer L. Barnas, Jennifer H. Anolik, Sarah French, Maria Dall'Era, Avi Z. Rosenberg, Jeffrey Hodgin, Dawit S. Demeke, the Accelerating Medicines Partnership Rheumatoid Arthritis and Systemic Lupus Erythematosus (RA/SLE) Network, Michelle Petri, Andrea Fava   +21 more
wiley   +1 more source

The incidence and distribution of biopsy-proven renal diseases in children [PDF]

, 2012
The precise distribution pattern of pediatric renal diseases has seldom been reported especially for young children. In order to clarify the incidence and distribution of renal diseases in children, 599 renal biopsy specimens obtained from 547 pediatric ...
Taguchi, Takashi, Shirakawa, Toshihiko, Nakashima, Yumiko, Abe, Kuniko, Nakayama, Toshiyuki, Moriuchi, Hiroyuki, Nazneen, Arifa   +6 more
core  

Effect of Proteinuria and Glomerular Filtration Rate on Renal Outcome in Patients with Biopsy-Proven Benign Nephrosclerosis. [PDF]

PLoS ONE, 2016
BACKGROUND:Reduced estimated glomerular filtration rate (eGFR) and proteinuria are risk factors for end-stage renal disease (ESRD), of which benign nephrosclerosis is a common cause.
Keiichi Sumida, Junichi Hoshino, Toshiharu Ueno, Koki Mise, Noriko Hayami, Tatsuya Suwabe, Masahiro Kawada, Aya Imafuku, Rikako Hiramatsu, Eiko Hasegawa, Masayuki Yamanouchi, Naoki Sawa, Takeshi Fujii, Kenichi Ohashi, Kenmei Takaichi, Yoshifumi Ubara   +15 more
doaj   +1 more source

Renal biopsy pathology in a cohort of patients from southwest Sydney with clinically diagnosed systemic lupus erythematosus [PDF]

, 2013
Purpose: The pathological manifestations in the kidneys in systemic lupus erythematosus (SLE) are commonly known as lupus nephritis. We have studied the pathological changes in renal biopsies from 59 cases of clinically diagnosed SLE obtained over a 15 ...
Lai, K, Yong, J, Killingsworth, Murray C., Lai, Ken (R17310), Killingsworth, MC ; https://orcid.org/, Yong, Jim L. (R14529)   +5 more
core   +1 more source

Real‐World Safety and Effectiveness of JAK Inhibitors in Systemic Sclerosis: A Propensity‐Matched Study From the EUSTAR Cohort

Arthritis Care &Research, EarlyView.
Objective JAK inhibitors (JAKi) have shown promising effects in early‐phase studies of systemic sclerosis (SSc). We aimed to assess the safety and explore the effectiveness of JAKi compared to conventional immunosuppressants in SSc. Methods A longitudinal retrospective study of the European Scleroderma Trials and Research Group (EUSTAR) cohort was ...
Stefano Di Donato, Marie‐Elise Truchetet, Marco Minerba, Oliver Distler, Juan José Alegre Sancho, Yolanda Braun‐Moscovici, Christina Bergmann, Petros Sfikakis, Jeska K. de Vries‐Bouwstra, Murray Baron, Silvia Bellando‐Randone, Lorenzo Dagna, Christopher P. Denton, Madelon C. Vonk, Vanessa Smith, Ivan Castellvi, Gabriela Riemekasten, Andra Balanescu, Masataka Kuwana, Maria De Santis, Kamal Solanki, Anastas Batalov, Vahan Mukuchyan, Marco Matucci‐Cerinic, Yannick Allanore, Francesco Del Galdo, Michael Hughes, EUSTAR Collaborators   +27 more
wiley   +1 more source